Sinocare Inc. (SHE: 300298)

Market Cap	14.01B
Revenue (ttm)	4.21B
Net Income (ttm)	221.71M
Shares Out	553.84M
EPS (ttm)	0.40
PE Ratio	63.29
Forward PE	38.42
Dividend	0.20 (0.77%)
Ex-Dividend Date	n/a

Volume	6,684,218
Open	26.28
Previous Close	25.71
Day's Range	25.80 - 26.68
52-Week Range	19.19 - 35.46
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 21, 2025

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It als...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 4,531
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300298

Financial Performance

In 2023, Sinocare's revenue was 4.06 billion, an increase of 2.69% compared to the previous year's 3.95 billion. Earnings were 284.40 million, a decrease of -36.31%.